Nuveen Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$1.8M Hold
405,354
﹤0.01% 2429
2024
Q3
$1.67M Sell
405,354
-54,087
-12% -$223K ﹤0.01% 2505
2024
Q2
$3M Sell
459,441
-1,383,802
-75% -$9.02M ﹤0.01% 2187
2024
Q1
$16.1M Buy
1,843,243
+6,918
+0.4% +$60.3K ﹤0.01% 1311
2023
Q4
$21M Buy
1,836,325
+706,218
+62% +$8.08M 0.01% 1129
2023
Q3
$10.9M Sell
1,130,107
-582,623
-34% -$5.61M ﹤0.01% 1428
2023
Q2
$18.2M Buy
1,712,730
+107,634
+7% +$1.15M 0.01% 1124
2023
Q1
$16.9M Sell
1,605,096
-204,093
-11% -$2.15M 0.01% 1157
2022
Q4
$22.4M Buy
1,809,189
+97,790
+6% +$1.21M 0.01% 960
2022
Q3
$17.7M Sell
1,711,399
-536,357
-24% -$5.56M 0.01% 1101
2022
Q2
$25.9M Buy
2,247,756
+28,183
+1% +$325K 0.01% 867
2022
Q1
$27.4M Buy
2,219,573
+115,934
+6% +$1.43M 0.01% 993
2021
Q4
$23.2M Sell
2,103,639
-192,522
-8% -$2.12M 0.01% 1131
2021
Q3
$28.4M Sell
2,296,161
-11,444
-0.5% -$141K 0.01% 1028
2021
Q2
$29.7M Buy
2,307,605
+910,801
+65% +$11.7M 0.01% 1081
2021
Q1
$15.6M Buy
1,396,804
+527,067
+61% +$5.89M 0.01% 1502
2020
Q4
$9.91M Sell
869,737
-220,206
-20% -$2.51M ﹤0.01% 1718
2020
Q3
$9.8M Sell
1,089,943
-400,350
-27% -$3.6M ﹤0.01% 1540
2020
Q2
$15.4M Buy
1,490,293
+500,309
+51% +$5.16M 0.01% 1209
2020
Q1
$9.99M Buy
989,984
+387,960
+64% +$3.91M ﹤0.01% 1294
2019
Q4
$8.01M Sell
602,024
-415,725
-41% -$5.53M ﹤0.01% 1724
2019
Q3
$8.74M Buy
1,017,749
+92,092
+10% +$791K ﹤0.01% 1655
2019
Q2
$10.1M Buy
+925,657
New +$10.1M ﹤0.01% 1605